Shareholder alert: robbins llp investigates aligos therapeutics, inc. (algs) on behalf of shareholders

San diego--(business wire)---- $algs #classaction--aligos therapeutics, inc. (algs) halted development of its lead drug candidate

ALGS Ratings Summary

ALGS Quant Ranking